" /> Breast cancer 10Y risk of distant recurrence classification:Imp:Pt: Patient:Ord:Prosigna - CISMeF





Preferred Label : Breast cancer 10Y risk of distant recurrence classification:Imp:Pt: Patient:Ord:Prosigna;

LOINC status : ACTIVE;

LOINC display name : Breast cancer 10-year risk of distant recurrence classification Prosigna Ql [Interp];

LOINC long common name : Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna;

LOINC short name : Brst ca 10Y dist recur class Prosigna;

LOINC description : The risk classification is an ordinal risk category (low, intermediate, high) that indicates a patient's risk of recurrence of breast cancer at 10 years. The classification is based on the 10-year risk of distant recurrence score and lymph node status. Low risk is associated with a 3% chance (confidence interval 2-6%), intermediate risk is associated with a 10% chance (confidence interval 7-14%), and high risk with a 16% chance (confidence interval 11-22%) of distant breast cancer recurrence at 10 years, respectively. [PMID: 24347518] This term was created for the Prosigna Breast Cancer Prognostic Gene Signature assay, which is intended for use in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), hormone receptor-positive (HR ) breast cancer who have undergone surgery and are to be treated with adjuvant endocrine therapy alone.;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.